DRUG

Bright Minds Biosciences Inc.

Insider Trades

NameValueActionPriceCurrent Price
Cormorant Asset Management, LP10 Percent Owner
$1.1M238.1k shares
BuyOct 15, 2024
$4.53
--
Cormorant Asset Management, LP10 Percent Owner
$374k63.2k shares
BuyOct 15, 2024
$5.92
--
Cormorant Asset Management, LP10 Percent Owner
$214k33.3k shares
BuyOct 15, 2024
$6.42
--
Cormorant Asset Management, LP10 Percent Owner
$65k8.9k shares
BuyOct 15, 2024
$7.31
--
Cormorant Asset Management, LP10 Percent Owner
$23k2.6k shares
BuyOct 15, 2024
$8.80
--
Cormorant Asset Management, LP10 Percent Owner
$25k2.7k shares
BuyOct 15, 2024
$9.26
--

News

globenewswire.comBright Minds Biosciences to Present at Jefferies Global Healthcare Conferenceglobenewswire.comMay 26fool.comWhy a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipelinefool.comMay 21defenseworld.netBright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of “Moderate Buy” from Brokeragesdefenseworld.netMar 28